High Dietary Sodium Blunts Effects of Angiotensin-converting Enzyme Inhibition on Vascular Angiotensin I-to-Angiotensin II Conversion in Rats

Journal of Cardiovascular Pharmacology

Volumn 42, Issue 5, 2003, Pages 601-606

  Kocks, Menno J A ^a,c   Buikema, Hendrik ^a   Gschwend, Simone ^a   Boomsma, Frans ^b   De Zeeuw, Dick ^a   Navis, Gerjan ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Angiotensin converting enzyme inhibitor; Aorta; Dietary sodium; Rat; Vascular angiotensin I conversion

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN I; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LISINOPRIL;

ANIMAL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; COMPARATIVE STUDY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ENZYME INHIBITION; IN VITRO STUDY; METABOLISM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RAT STRAIN; SODIUM INTAKE; THORACIC AORTA; VASCULAR RING; VASOCONSTRICTION;

ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; AORTA, THORACIC; DOSE-RESPONSE RELATIONSHIP, DRUG; RATS; RATS, WISTAR; SODIUM, DIETARY;

EID: 0142139285     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200311000-00004     Document Type: Article

References (28)

1. Navis G, de Jong P, Donker AJ, et al. Diuretic effects of angiotensin-converting enzyme inhibition: comparison of low and liberal sodium diet in hypertensive patients. J Cardiovasc Pharmacol. 1987;9:743-748.
2. Chrysant SG, Weder AB, McCarron DA, et al. Effects of isradipine or enalapril on blood pressure in salt-sensitive hypertensives during low and high dietary salt intake. MIST II Trial Investigators. Am J Hypertens. 2000;13:1180-1188.
3. Heeg JE, de Jong PE, van der Hem GK, et al. Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril. Kidney Int. 1989;36:272-279.
4. Teravainen TL, Mervaala EM, Laakso J, et al. Influence of age on cardiovascular effects of increased dietary sodium and angiotensin-converting enzyme inhibition in normotensive Wistar rats. J Pharm Pharmacol. 1997;49:912-918.
5. Morgan T. Interactions between sodium and angiotensin. Clin Exp Pharmacol Physiol. 2001;28:1070-1073.
6. Dzau VJ, Bernstein K, Celermajer D, et al. The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data. Am J Cardiol. 2001;88(suppl 9):1L-20L.
7. Fernandez-Alfonso MS, Kreutz R, Zeh K, et al. Differential regulation of vascular angiotensin I-converting enzyme in hypertension. Hypertension. 1994;24:280-286.
8. Boddi M, Poggesi L, Coppo M, et al. Human vascular renin-angiotensin system and its functional changes in relation to different sodium intakes. Hypertension. 1998;31:836-842.
9. Buikema H, Pinto YM, van Geel PP, et al. Differential inhibition of plasma versus tissue ACE by utibapril: biochemical and functional evidence for inhibition of vascular ACE activity. J Cardiovasc Pharmacol. 1997;29:684-691.
10. Admiraal PJ, Derkx FH, Danser AH. Metabolism and production of angiotensin I in different vascular beds in subjects with hypertension. Hypertension. 1990;15:44-55.
11. Hirsch AT, Talsness CE, Schunkert H, et al. Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure. Circ Res. 1991;69:475-482.
12. Voors AA, Pinto YM, Buikema H, et al. Dual pathway for angiotensin II formation in human internal mammary arteries. Br J Pharmacol. 1998; 125:1028-1032.
13. Gonzalez C, Gomez C, Molero F, et al. The upregulation of angiotensin-converting enzyme during neointima formation does not have functional consequences. Life Sci. 2001;69:1851-1860.
14. Buikema H, Pinto YM, Rooks G, et al. The deletion polymorphism of the angiotensin-converting enzyme gene is related to phenotypic differences in human arteries. Eur Heart J. 1996;17:787-794.
15. Schuijt MP, de Vries R, Saxena PR, et al. Vasoconstriction is determined by interstitial rather than circulating angiotensin II. Br J Pharmacol. 2002; 135:275-283.
16. van der Kleij FG, de Jong PE, Henning RH, et al. Enhanced responses of blood pressure, renal function, and aldosterone to angiotensin I in the DD genotype are blunted by low sodium intake. J. Am. Soc. Nephrol. 2002;13:1025-1033.
17. Luik PT, Hoogenberg K, van der Kleij FG, et al. Short-term moderate sodium restriction induces relative hyperfiltration in normotensive normoalbuminuric Type I diabetes mellitus. Diabetologia. 2002;45: 535-541.
18. Ingert C, Grima M, Coquard C, et al. Effects of dietary salt changes on renal renin-angiotensin system in rats. Am J Physiol Renal Physiol. 2002; 283:F995-F1002.
19. Wapstra FH, van Goor H, Navis G, et al. Antiproteinuric effect predicts renal protection by angiotensin-converting enzyme inhibition in rats with established adriamycin nephrosis. Clin Sci (Lond). 1996;90:393-401.
20. Waeber B, Nussberger J, Juillerat L, et al. Angiotensin converting enzyme inhibition: discrepancy between antihypertensive effect and suppression of enzyme activity. J Cardiovasc Pharmacol. 1989;14(Suppl 4):S53-S59.
21. Duncan AM, Burrell LM, Kladis A, et al. Effects of angiotensin-converting enzyme inhibition on angiotensin and bradykinin peptides in rats with myocardial infarction. J Cardiovasc Pharmacol. 1996;28: 746-754.
22. Yamada K, Iyer SN, Chappell MC, et al. Converting enzyme determines plasma clearance of angiotensin-(1-7). Hypertension. 1998;32:496-502.
23. Kikta DC, Fregly MJ. Effect of in vitro administration of captopril on vascular reactivity of rat aorta. Hypertension. 1982;4:118-124.
24. Aguilera G, Catt K. Regulation of vascular angiotensin II receptors in the rat during altered sodium intake. Circ Res. 1981;49:751-758.
25. Du Y, Yao A, Guo D, et al. Differential regulation of angiotensin II receptor subtypes in rat kidney by low dietary sodium. Hypertension. 1995;25(4 Pt 2):872-877.
26. Hollenberg NK, Osei SY, Lansang MC, et al. Salt intake and non-ACE pathways for intrarenal angiotensin II generation in man. J Renin Angiotensin Aldosterone Syst. 2001;2:14-18.
27. Akasu M, Urata H, Kinoshita A, et al. Differences in tissue angiotensin II-forming pathways by species and organs in vitro. Hypertension. 1998; 32:514-520.
28. Wei CC, Tian B, Perry G, et al. Differential ANG II generation in plasma and tissue of mice with decreased expression of the ACE gene. Am J Physiol Heart Circ Physiol. 2002;282:H2254-H2258.